118 related articles for article (PubMed ID: 2713488)
1. Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.
Thompson JA; Kidd P; Rubin E; Fefer A
Blood; 1989 May; 73(6):1440-3. PubMed ID: 2713488
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
3. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
Kloke O; May D; Wandl U; Niederle N
Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
[TBL] [Abstract][Full Text] [Related]
4. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
[TBL] [Abstract][Full Text] [Related]
5. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
Holmes R; Schwarz MA; Whiteside MG; Firkin FC
Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
9. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
Ratain MJ; Golomb HM; Bardawil RG; Vardiman JW; Westbrook CA; Kaminer LS; Lembersky BC; Bitter MA; Daly K
Blood; 1987 Mar; 69(3):872-7. PubMed ID: 3814819
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
[TBL] [Abstract][Full Text] [Related]
11. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
12. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
Rai KR; Davey F; Peterson B; Schiffer C; Silver RT; Ozer H; Golomb H; Bloomfield CD
Leukemia; 1995 Jul; 9(7):1116-20. PubMed ID: 7630181
[TBL] [Abstract][Full Text] [Related]
13. The treatment of hairy cell leukemia with alpha 2b-interferon: experience with 27 patients treated more than one year.
Thompson JA; Rubin E; Fefer A
Leukemia; 1987 Apr; 1(4):328-30. PubMed ID: 3669756
[TBL] [Abstract][Full Text] [Related]
14. Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected].
Klingemann HG; Grigg AP; Wilkie-Boyd K; Barnett MJ; Eaves AC; Reece DE; Shepherd JD; Phillips GL
Blood; 1991 Dec; 78(12):3306-11. PubMed ID: 1742491
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.
Golomb HM; Ratain MJ; Fefer A; Thompson J; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Bonnem E
J Natl Cancer Inst; 1988 May; 80(5):369-73. PubMed ID: 3282078
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
[TBL] [Abstract][Full Text] [Related]
18. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukaemia: evaluation of response and maintenance dose.
Nielsen B; Braide I
Eur J Haematol; 1992 Oct; 49(4):174-9. PubMed ID: 1343089
[TBL] [Abstract][Full Text] [Related]
19. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
Thompson JA; Brady J; Kidd P; Fefer A
Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.
Smalley RV; Anderson SA; Tuttle RL; Connors J; Thurmond LM; Huang A; Castle K; Magers C; Whisnant JK
Blood; 1991 Dec; 78(12):3133-41. PubMed ID: 1742480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]